People: AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

10.71USD
24 May 2013
Price Change (% chg)

$0.04 (+0.37%)
Prev Close
$10.67
Open
$10.64
Day's High
$10.75
Day's Low
$10.54
Volume
66,241
Avg. Vol
121,750
52-wk High
$12.91
52-wk Low
$9.52

Search Stocks

Donnelly, Howard 

Brief Biography

Mr. Howard W. Donnelly is Independent Director of AngioDynamics Inc., since March 2004. Mr. Donnelly is President of Concert Medical, LLC, a manufacturer of interventional medical devices. On July 30, 2010, Mr. Donnelly became a principal and President and CEO of HydroCision Inc., a company focused on the spine surgery market. In addition, Mr. Donnelly is a principal in a privately held start-up medical device company targeting the regional anesthetic market. From 2002 to 2008, Mr. Donnelly was a director and member of the audit, compensation and nominating and governance committees of Vital Signs, Inc. From 1999 to 2002, he was President of Level 1, Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990 to 1999, Mr. Donnelly was employed at Pfizer, Inc., with his last position as Vice President, Business Planning and Development, for Pfizer’s Medical Technology Group from 1997 to 1999. Mr. Donnelly holds a B.S. and an M.B.A. from Bryant College. Mr. Donnelly is chairman of Company's Licensing and Acquisition Committee and a member of Company's Audit Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Vincent Bucci

15,914

Joseph DeVivo

3,532,210

Mark Frost

--

George Bourne

--

Stephen McGill

496,559

Alan Panzer

1,264,280
As Of 30 May 2012
Search Stocks